Catalyst Biosciences

+$0.09 (+6.72%) Today

-$0.03 (-2.10%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CBIO and other ETFs, options, and stocks.

About CBIO

Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions.

CEO

Nassim Usman

Employees

Headquarters

South San Francisco, California

Founded

1997

CBIO Key Statistics

Market cap

Price-Earnings ratio

—

Dividend yield

—

Average volume

32.23M

High today

$1.52

Low today

$1.20

Open price

$1.22

Volume

30.77M

52 Week high

$5.20

52 Week low

$0.3501

CBIO News

BenzingaMay 24

Short Volatility Alert: Catalyst Biosciences

On Modnay, shares of Catalyst Biosciences, Inc. CBIO experienced volatile short activity. After the activity, the stock price went up +234.21% to $1.27. The ove

MarketWatchMay 23

Catalyst Biosciences Shares Soar After Complement Portfolio Sale >CBIO - MarketWatch

By Colin Kellaher Shares of Catalyst Biosciences Inc. more than doubled in early trading Monday after the biopharmaceutical company said it sold its portfolio

CBIO Earnings

-$0.86

-$0.57

-$0.29

$0.00

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Estimated

— per share

Actual

Expected Aug 4, Pre-Market

Why Robinhood?

Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. View more

Short Volatility Alert: Catalyst Biosciences

Catalyst Biosciences Shares Soar After Complement Portfolio Sale >CBIO - MarketWatch

Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions.